People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.

by Kate Yandell

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett

New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

Survivor Profile

With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

by Lindsey Konkel

From the Editor-in-Chief

Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

by William G. Nelson, MD, PhD

Sound Advice

vol 11 | issue 01
Maintaining relationships through cancer, feeling unappreciated as a caregiver, and finding information that's relevant to young people with cancer.

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua

After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.

by Miriam Díaz-Gilbert

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey